Abstract
Enzyme inhibitors are crucial therapeutic agents that play an essential role in the treatment of a variety of diseases, including cancer, hypertension, and infectious diseases. These inhibitors function by binding to enzymes and blocking their activity, thus modulating physiological processes. This paper aims to explore the mechanisms of enzyme inhibition, the different classes of enzyme inhibitors, their applications in drug therapy, and the clinical implications of their use. We also discuss the potential challenges and future directions in enzyme inhibitor-based therapies.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.